Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amarin - 26 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits. The latest closing stock price for Amarin as of September 19, 2019 is 16.94.
  • The all-time high Amarin stock closing price was 1375.00 on July 13, 1993.
  • The Amarin 52-week high stock price is 23.91, which is 41.1% above the current share price.
  • The Amarin 52-week low stock price is 9.51, which is 43.9% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 17.98.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 18.0064 13.0100 23.1600 12.6100 16.9400 24.47%
2018 7.2152 4.2400 22.9800 2.4500 13.6100 239.40%
2017 3.3183 3.0900 4.2900 2.8700 4.0100 30.19%
2016 2.3426 1.8100 3.4700 1.2700 3.0800 62.96%
2015 2.0071 1.1300 2.9000 1.0000 1.8900 92.92%
2014 1.5196 1.9600 2.4000 0.8323 0.9797 -50.27%
2013 5.9094 8.1000 9.1600 1.4000 1.9700 -75.65%
2012 11.0818 7.0500 15.4600 6.3500 8.0900 8.01%
2011 10.7040 8.3300 19.5000 6.0300 7.4900 -8.67%
2010 2.6540 1.3800 8.4900 0.9800 8.2010 473.54%
2009 1.1927 0.6800 1.9501 0.5200 1.4299 101.39%
2008 1.9011 2.5000 3.5899 0.6000 0.7100 -72.69%
2007 10.0092 21.8000 37.8000 2.2500 2.6000 -88.60%
2006 26.1466 13.5000 37.4000 12.7000 22.8000 90.00%
2005 17.9218 26.2000 34.0000 10.6000 12.0000 -55.72%
2004 13.8964 15.4000 39.9000 5.3000 27.1000 75.97%
2003 29.0139 39.4000 48.1000 13.9000 15.4000 -61.40%
2002 84.0659 171.0000 210.0000 27.6000 39.9000 -77.03%
2001 132.7548 55.0000 279.7000 50.0000 173.7000 215.82%
2000 59.7940 45.0000 77.8000 37.5000 55.0000 15.79%
1999 70.4238 44.4000 113.8000 41.3000 47.5000 33.43%
1998 103.3595 306.0000 306.0000 10.0000 35.6000 -88.59%
1997 502.1937 581.0000 662.0000 294.0000 312.0000 -46.30%
1996 848.2008 900.0000 1125.0000 550.0000 581.0000 -35.44%
1995 727.3135 650.0000 1000.0000 500.0000 900.0000 38.46%
1994 772.7659 875.0000 1050.0000 481.0000 650.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.048B $0.229B
Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.966B 13.32
Gilead Sciences (GILD) United States $83.231B 10.22
CSL (CSLLY) Australia $72.709B 0.00
Celgene (CELG) United States $69.932B 10.82
Vertex Pharmaceuticals (VRTX) United States $44.858B 48.48
Illumina (ILMN) United States $44.542B 52.33
Biogen (BIIB) United States $43.376B 7.71
Regeneron Pharmaceuticals (REGN) United States $31.308B 14.21
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.091B 12.17
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.891B 49.71
Exact Sciences (EXAS) United States $13.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.549B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.778B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.507B 0.00
Galapagos (GLPG) Belgium $8.668B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.518B 51.94
Guardant Health (GH) United States $6.852B 0.00
Sarepta Therapeutics (SRPT) United States $6.220B 0.00
BeiGene (BGNE) Cayman Islands $6.215B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.092B 0.00
Bluebird Bio (BLUE) United States $5.938B 0.00
Moderna (MRNA) United States $5.871B 0.00
Exelixis (EXEL) United States $5.837B 15.17
Horizon Pharma Public (HZNP) Ireland $4.924B 12.52
ARGENX SE-ADR (ARGX) Netherlands $4.890B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.228B 82.04
China Biologic Products (CBPO) China $4.060B 25.34
Spark Therapeutics (ONCE) United States $4.007B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
Medicines (MDCO) United States $3.756B 0.00
MorphoSys AG (MOR) Germany $3.690B 0.00
Mirati Therapeutics (MRTX) United States $3.606B 0.00
Alkermes (ALKS) Ireland $3.375B 0.00
Immunomedics (IMMU) United States $3.246B 0.00
Emergent Biosolutions (EBS) United States $2.749B 41.29
Reata Pharmaceuticals (RETA) United States $2.714B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.700B 0.00
Genomic Health (GHDX) United States $2.652B 49.73
Arena Pharmaceuticals (ARNA) United States $2.605B 5.60
MyoKardia (MYOK) United States $2.566B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.512B 0.00
Amicus Therapeutics (FOLD) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.402B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.255B 120.61
Myriad Genetics (MYGN) United States $2.053B 21.55
Akcea Therapeutics (AKCA) United States $2.041B 0.00
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.998B 0.00
Ligand Pharmaceuticals (LGND) United States $1.887B 23.86
Denali Therapeutics (DNLI) United States $1.763B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Insmed (INSM) United States $1.730B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.658B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.565B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
REGENXBIO (RGNX) United States $1.421B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.399B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.335B 0.00
Alector (ALEC) United States $1.324B 0.00
Editas Medicine (EDIT) United States $1.252B 0.00
Sangamo Therapeutics (SGMO) United States $1.246B 0.00
RA PHARMCTL INC (RARX) United States $1.212B 0.00
AnaptysBio (ANAB) United States $1.154B 0.00
Fate Therapeutics (FATE) United States $1.151B 0.00
Innoviva (INVA) United States $1.126B 3.25
Athenex (ATNX) United States $1.093B 0.00
Epizyme (EPZM) United States $1.069B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Twist Bioscience (TWST) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.929B 0.00
ANI Pharmaceuticals (ANIP) United States $0.884B 14.77
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.860B 0.00
Principia Biopharma (PRNB) United States $0.838B 436.88
Arvinas (ARVN) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.793B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Cytokineticsorporated (CYTK) United States $0.766B 0.00
UROGEN PHARMA (URGN) United States $0.757B 0.00
Anika Therapeutics (ANIK) United States $0.749B 26.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.744B 0.00
Intellia Therapeutics (NTLA) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.712B 0.00
Mesoblast (MESO) Australia $0.708B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.703B 25.36
Revance Therapeutics (RVNC) United States $0.617B 0.00
MiMedx (MDXG) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.579B 0.00
Heska (HSKA) United States $0.546B 70.74
Achillion Pharmaceuticals (ACHN) United States $0.532B 0.00
Retrophin (RTRX) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Cellectis S.A (CLLS) France $0.521B 0.00
Stemline Therapeutics (STML) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.504B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.502B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.429B 0.00
Arcus Biosciences (RCUS) United States $0.424B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Agenus (AGEN) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Gritstone Oncology (GRTS) United States $0.350B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Prothena (PRTA) Ireland $0.342B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
Theratechnologies (THERF) Canada $0.327B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
ADMA Biologics Inc (ADMA) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Kindred Biosciences (KIN) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
Cel-Sci (CVM) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Dynavax Technologies (DVAX) United States $0.289B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Clovis Oncology (CLVS) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.276B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
MannKind (MNKD) United States $0.254B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
PDL BioPharma (PDLI) United States $0.249B 6.41
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Affimed (AFMD) Germany $0.228B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Athersys (ATHX) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.224B 0.00
Compugen (CGEN) Israel $0.220B 0.00
EXICURE INC (XCUR) United States $0.217B 0.00
Palatin Technologies (PTN) United States $0.215B 6.32
Bicycle Therapeutics (BCYC) United Kingdom $0.213B 0.00
Kamada (KMDA) Israel $0.207B 7.92
CorMedix Inc (CRMD) United States $0.203B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
Five Prime Therapeutics (FPRX) United States $0.196B 0.00
XOMA (XOMA) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Arsanis (XFOR) United States $0.175B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.168B 0.00
Alcobra (ARCT) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Novavax (NVAX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
PHASEBIO PHARMA (PHAS) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Mersana Therapeutics (MRSN) United States $0.087B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.084B 0.00
Selecta Biosciences (SELB) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
VBI Vaccines (VBIV) United States $0.066B 0.00
AquaBounty Technologies (AQB) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.048B 0.00
Stellar Biotechnologies (EDSA) Canada $0.046B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
BIOCARDIA INC (BCDA) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Apricus Biosciences (SEEL) United States $0.027B 0.00
Clearside Biomedical (CLSD) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00